Middle East and Africa Immunoassay-Gamma Counters Market Analysis, Demand & Growth Forecast

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRODUCT TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTEL ANALYSIS

4.2 PORTES FIVE FORCES

5 REGULATORY GUIDELINES FOR IMMUNOASSAY-GAMMA COUNTERS

5.1 U.S. REGULATORY GUIDELINES FOR IMMUNOASSAYS-GAMMA COUNTERS

5.2 EUROPE REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

5.3 JAPAN REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

5.4 CHINA REGULATORY GUIDELINE FOR IMMUNOASSAY-GAMMA COUNTERS

6 MARKET OVERVIEW

6.1 DRIVERS

6.1.1 INCREASE IN PREVALENCE OF CHRONIC DISEASES

6.1.2 PRODUCT APPROVAL

6.1.3 INCREASE IN ADOPTION OF NUCLEAR MEDICINE

6.1.4 NOVELTY IN DIAGNOSIS PROCEDURES

6.1.5 UPGRADING GAMMA TECHNOLOGY

6.2 RESTRAINTS

6.2.1 HIGH COST OF GAMMA COUNTER

6.2.2 RISK OF GAMMA RADIATION

6.2.3 STRINGENT REGULATION OF CLINICAL USE OF GAMMA COUNTER

6.2.4 PRODUCT RECALL

6.3 OPPORTUNITIES

6.3.1 GROWING RESEARCH AND DEVELOPMENT EXPENDITURE

6.3.2 INCREASE IN HEALTHCARE EXPENDITURE

6.3.3 RISE IN PATIENTS AWARENESS TOWARDS CHRONIC DISEASE TREATMENT

6.4 CHALLENGES

6.4.1 CHALLENGES IN USING GAMMA COUNTER

6.4.2 LACK OF SKILLED AND CERTIFIED PROFESSIONALS

7 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET

7.1 IMPACT ON THE PRICE

7.2 IMPACT ON DEMAND

7.3 IMPACT ON SUPPLY

7.4 STRATEGIC INITIATIVES BY MANUFACTURERS

7.5 CONCLUSION

8 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE

8.1 OVERVIEW

8.2 AUTOMATED

8.2.1 RADIOIMMUNOASSAYS

8.2.1.1 RIA

8.2.1.2 IRMA

8.2.2 NUCLEAR MEDICINE ASSAYS

8.2.2.1 GFR (Glomerular FILTRATION RATE)

8.2.2.2 Gamma glutamyl transferase (ggt)

8.2.2.3 red cell mass and plasma volume test

8.2.2.4 THE SCHILLING TEST

8.2.2.5 others

8.2.3 OTHERS

8.3 MANUAL/SEMI-AUTOMATED

8.3.1 RADIOIMMUNOASSAYS

8.3.1.1 RIA

8.3.1.2 IRMA

8.3.2 NUCLEAR MEDICINE ASSAYS

8.3.2.1 GFR (Glomerular FILTRATION RATE)

8.3.2.2 Gamma glutamyl transferase (ggt)

8.3.2.3 red cell mass and plasma volume test

8.3.2.4 THE SCHILLING TEST

8.3.2.5 others

8.3.3 OTHERS

9 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL

9.1 OVERVIEW

9.2 MULTI-WELL

9.3 SINGLE-WELL

10 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION

10.1 OVERVIEW

10.2 RADIO IMMUNOASSAYS

10.2.1 RIA

10.2.2 IRMA

10.3 NUCLEAR MEDICINE ASSAY

10.3.1 GFR (GLOMERULAR FILTRATION RATE)

10.3.2 GAMMA-GLUTAMYL TRANSFERASE

10.3.3 RED CELL MASS AND PLASMA VOLUME TEST

10.3.4 THE SCHILLING TEST

10.3.5 OTHERS

10.4 OTHERS

11 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION

11.1 OVERVIEW

11.2 CANCER BIOMARKERS

11.2.1 CARBOHYDRATE ANTIGEN 125 (CA125)

11.2.2 CARBOHYDRATE ANTIGEN 19-9

11.2.3 CARCINO EMBRYONIC ANTIGEN

11.2.4 ALPHA-FETOPROTEIN

11.2.5 OTHERS

11.3 INFECTIOUS DISEASES

11.4 THERAPEUTIC DRUG MONITORING

11.5 ENDOCRINE HORMONES

11.6 ALLERGY

11.7 NEONATAL SCREENING

11.8 CARDIAC MARKERS

11.9 AUTOIMMUNE DISEASE

11.1 OTHERS

12 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE

12.1 OVERVIEW

12.2 OUTRIGHT PURCHASE

12.3 RENTAL PURCHASE

13 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL

13.1 OVERVIEW

13.2 DIRECT TENDER

13.3 THIRD PARTY DISTRIBUTORS

14 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER

14.1 OVERVIEW

14.2 HOSPITALS

14.3 LABORATORY

14.4 BLOOD BANKS

14.5 RESEARCH AND ACADEMIC INSTITUTES

14.6 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES

14.7 OTHERS

15 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY GEOGRAPHY

15.1 MIDDLE EAST & AFRICA

15.1.1 SOUTH AFRICA

15.1.2 SAUDI ARABIA

15.1.3 U.A.E.

15.1.4 ISRAEL

15.1.5 EGYPT

15.1.6 REST OF MIDDLE EAST & AFRICA

16 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

17 SWOT ANALYSIS

18 COMPANY PROFILE

18.1 PERKINELMER INC.

18.1.1 COMPANY SNAPSHOT

18.1.2 REVENUE ANALYSIS

18.1.3 COMPANY SHARE ANALYSIS

18.1.4 PRODUCT PORTFOLIO

18.1.5 RECENT DEVELOPMENTS

18.2 BRETHOLD TECHNOLOGIES GMBH & CO.KG

18.2.1 COMPANY SNAPSHOT

18.2.2 COMPANY SHARE ANALYSIS

18.2.3 PRODUCT PORTFOLIO

18.2.4 RECENT DEVELOPMENTS

18.3 LABLOGIC SYSTEMS LTD.

18.3.1 COMPANY SNAPSHOT

18.3.2 COMPANY SHARE ANALYSIS

18.3.3 PRODUCT PORTFOLIO

18.3.4 RECENT DEVELOPMENT

18.4 SHIN JIN MEDICS INC.

18.4.1 COMPANY SNAPSHOT

18.4.2 COMPANY SHARE ANALYSIS

18.4.3 PRODUCT PORTFOLIO

18.4.4 RECENT DEVELOPMENTS

18.5 HIDEX OY

18.5.1 COMPANY SNAPSHOT

18.5.2 COMPANY SHARE ANALYSIS

18.5.3 PRODUCT PORTFOLIO

18.5.4 RECENT DEVELOPMENTS

18.6 LABORATORY TECHNOLOGIES. INC.

18.6.1 COMPANY SNAPSHOT

18.6.2 PRODUCT PORTFOLIO

18.6.3 RECENT DEVELOPMENT

18.7 ENERSYS, CO.LTD.

18.7.1 COMPANY SNAPSHOT

18.7.2 PRODUCT PORTFOLIO

18.7.3 RECENT DEVELOPMENTS

18.8 MIRION TECHNOLOGIES (CAPINTEC),INC.

18.8.1 COMPANY SNAPSHOT

18.8.2 PRODUCT PORTFOLIO

18.8.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

List of Table

TABLE 1 NUMBER OF PEOPLE WITH DIABETES (MILLION) AMONG AGES 20–79 YEARS

TABLE 2 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 3 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA MANUAL/SEMI-AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA MULTI-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA SINGLE-WELL IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA RADIO IMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE ASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA INFECTIOUS DISEASES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA THERAPEUTIC DRUG MONITORING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA ENDOCRINE HORMONES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA ALLERGY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA NEONATAL SCREENING IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA CARDIAC MAKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA AUTO IMMUNE DISEASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA OUTRIGHT PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA RENTAL PURCHASE IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY REGION, 2015-2028 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA DIRECT TENDER IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA HOSPITALS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA LABORATORY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA BLOOD BANKS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 20152028 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA RESEARCH AND ACADEMIC INSTITUTES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 44 OTHERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY COUNTRY, 2015-2028 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE 2015-2028 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 56 MIDDLE EAST & AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 57 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 58 MIDDLE EAST & AFRICA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 59 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 60 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 61 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 62 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 63 SOUTH AFRICA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 64 SOUTH AFRICA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 65 SOUTH AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE 2015-2028 (USD MILLION)

TABLE 66 SOUTH AFRICA MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 67 SOUTH AFRICA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 68 SOUTH AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 69 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 70 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 71 SOUTH AFRICA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 72 SOUTH AFRICA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 73 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 74 SOUTH AFRICA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 75 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 76 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 77 SOUTH AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 78 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 79 SAUDI ARABIA AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 80 SAUDI ARABIA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 81 SAUDI ARABIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE 2015-2028 (USD MILLION)

TABLE 82 SAUDI ARABIA MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 83 SAUDI ARABIA RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 84 SAUDI ARABIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 85 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 86 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 87 SAUDI ARABIA RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 88 SAUDI ARABIA NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 89 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 90 SAUDI ARABIA CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 91 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 92 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 93 SAUDI ARABIA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 94 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 95 U.A.E. AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 96 U.A.E. RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 97 U.A.E. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE, 2015-2028 (USD MILLION)

TABLE 98 U.A.E. MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 99 U.A.E. RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 100 U.A.E. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 101 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 102 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 103 U.A.E. RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 104 U.A.E. NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 105 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 106 U.A.E. CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 107 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 108 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 109 U.A.E. IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 110 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 111 ISRAEL AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 112 ISRAEL RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 113 ISRAEL NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE 2015-2028 (USD MILLION)

TABLE 114 ISRAEL MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 115 ISRAEL RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 116 ISRAEL NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 117 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 118 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 119 ISRAEL RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 120 ISRAEL NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 121 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 122 ISRAEL CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 123 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 124 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 125 ISRAEL IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 126 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

TABLE 127 EGYPT AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 128 EGYPT RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 129 EGYPT NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT, TYPE 2015-2028 (USD MILLION)

TABLE 130 EGYPT MANUAL/SEMI AUTOMATED IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015 -2028 (USD MILLION)

TABLE 131 EGYPT RADIOIMMUNOASSAY IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 132 EGYPT NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY GAMMA COUNTERS MARKET, BY PRODUCT TYPE, 2015-2028 (USD MILLION)

TABLE 133 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY WELL, 2015-2028 (USD MILLION)

TABLE 134 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 135 EGYPT RADIOIMMUNOASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 136 EGYPT NUCLEAR MEDICINE ASSAYS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY APPLICATION, 2015-2028 (USD MILLION)

TABLE 137 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 138 EGYPT CANCER BIOMARKERS IN IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISEASE CONDITION, 2015-2028 (USD MILLION)

TABLE 139 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PURCHASE MODE, 2015-2028 (USD MILLION)

TABLE 140 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY END USER, 2015-2028 (USD MILLION)

TABLE 141 EGYPT IMMUNOASSAY-GAMMA COUNTERS MARKET, BY DISTRIBUTION CHANNEL, 2015-2028 (USD MILLION)

TABLE 142 REST OF MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET, BY PRODUCT TYPE , 2015-2028 (USD MILLION)

List of Figure

FIGURE 1 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: MULTIVARIATE MODELLING

FIGURE 7 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: APPLICATION COVERAGE GRID

FIGURE 10 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: VENDOR SHARE ANALYSIS

FIGURE 11 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: SEGMENTATION

FIGURE 12 INCREASE IN PREVALENCE OF CHRONIC DISEASES AND GROWING USE OF NUCLEAR MEDICINE IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 13 AUTOMATED IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET IN 2021 & 2028

FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET

FIGURE 15 HEALTH SPENDING BY MAJOR SOURCES OF FUNDS

FIGURE 16 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2020

FIGURE 17 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, 2021-2028 (USD MILLION)

FIGURE 18 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, CAGR (2021-2028)

FIGURE 19 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PRODUCT TYPE, LIFELINE CURVE

FIGURE 20 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2020

FIGURE 21 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, 2021-2028 (USD MILLION)

FIGURE 22 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, CAGR (2021-2028)

FIGURE 23 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY WELL, LIFELINE CURVE

FIGURE 24 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2020

FIGURE 25 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, 2021-2028 (USD MILLION)

FIGURE 26 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, CAGR (2021-2028)

FIGURE 27 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY APPLICATION, LIFELINE CURVE

FIGURE 28 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, 2020

FIGURE 29 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: BY DISEASE CONDITION, 2021-2028 (USD MILLION)

FIGURE 30 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, CAGR (2021-2028)

FIGURE 31 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISEASE CONDITION, LIFELINE CURVE

FIGURE 32 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2020

FIGURE 33 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, 2021-2028 (USD MILLION)

FIGURE 34 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, CAGR (2021-2028)

FIGURE 35 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY PURCHASE MODE, LIFELINE CURVE

FIGURE 36 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2020

FIGURE 37 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)

FIGURE 38 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 39 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 40 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2020

FIGURE 41 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, 2021-2028 (USD MILLION)

FIGURE 42 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, CAGR (2021-2028)

FIGURE 43 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET : BY END USER, LIFELINE CURVE

FIGURE 44 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: SNAPSHOT (2020)

FIGURE 45 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020)

FIGURE 46 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2021 & 2028)

FIGURE 47 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: BY COUNTRY (2020 & 2028

FIGURE 48 MIDDLE EAST & AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: BY PRODUCT TYPE (2021 &2028)

FIGURE 49 MIDDLE EAST AND AFRICA IMMUNOASSAY-GAMMA COUNTERS MARKET: COMPANY SHARE 2020 (%)